Bergapten

DB12216InvestigationalSmall molecule

Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis).

Formula / weight: C₁₂H₈O₄ · 216.192 g/mol (avg)
Also known as: 5 methoxypsoralen · 5-methoxypsoralen
Code names: NSC-95437

Resolves to

Compound

UNII4FVK84C92XCAS484-20-8ChEMBLCHEMBL24171ChEBI18293PubChem2355KEGGC01557

Clinical / RWD

RxNorm15842ATCD05BA03

Structure

InChIKeyBGEBZHIAGXMEMV-UHFFFAOYSA-NSMILESCOC1=C2C=CC(=O)OC2=CC2=C1C=CO2

What you can answer from here — as of July 07, 2026

21Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 17 drug categories

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Bergapten, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account